Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New collaborative care model shows promise for anxiety treatment

NCT ID NCT02678624

Symptom relief Sponsor: Amager Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a collaborative care model, called Collabri, works better than usual treatment for people with anxiety. The model involves a team including a care manager, general practitioner, and psychiatrist, with regular monitoring and a structured plan. 406 adults with generalized anxiety, social phobia, or panic disorder took part. The goal was to see if this approach reduces anxiety symptoms more effectively.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Collaborative care model (Collabri Model)
What this could lead to
If successful, this model could offer a more effective way to manage anxiety in primary care, reducing symptoms and improving daily functioning.
What could go wrong
This is a completed study, but results may not apply to all settings. The intervention is complex and may be hard to implement widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 406 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2014

Finished

Jul 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age: 18+ years * Danish speaking * Diagnosis of current depression using the Mini International Neuropsychiatric Interview (MINI) (DSM IV) by researchers that have been trained in using MINI and according to the ICD-10 criteria or when diagnosed by GP after conference with a psychiatrist in Project Collabri * The patient has given her/his written informed consent to participate in the trial at the described terms Exclusion Criteria: * High risk of suicide assessed in the Mini International Neuropsychiatric Interview (MINI) and/or by general practitioner * Psychotic condition detected in the MINI and/or by general practitioner * Patients with a diagnosis of dementia * Pregnancy * Alcohol or substance misuse that hinders the person participating in Collabri treatment as assessed by the practitioner or researcher at inclusion interview * Patients that are in current psychological or psychiatric treatment due to anxiety or depression * Patients with a pending disability pension case * Patients who have been treated for anxiety or depression within the last 6 months * For patients in the intervention group: Patients with depression who wants treatment cf. the Danish psychologist scheme and do not want the reference to the psychologist preceded by other treatment, cf. the Collabri model * For patients in the intervention group: If the patient at the first point of contact with the general practitioner after inclusion by a research assistant is referred to treatment as a part of the secondary psychiatric care system. * Patients who are assessed by the general practitioner as medically unstable making it impossible for the patient to adhere to treatment * OCD, PTSD, bipolar affective disorder as assessed in the MINI and/or by the general practitioner

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Generalized anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

generalized anxiety disorder panic disorder social phobia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Generalized anxiety Panic disorder Social phobia

Contacts and locations

Locations

  • Mental Health Centre Copenhagen

    Copenhagen, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.